| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate |
2018-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52d74d0fb451fc3583ee0b1c9e5a4f73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c195cfa592de80627a6c3aad0d51c1d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce87b20aba151a2804c80d2dbdba9508 |
| publicationDate |
2019-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201902896-A |
| titleOfInvention |
Therapeutic compounds and compositions and methods of use thereof |
| abstract |
Compounds and salts suitable for use as JAK kinase inhibitors are described herein. Also provided herein are pharmaceutical compositions that include such JAK inhibitors and a pharmaceutically acceptable carrier, adjuvant, or vehicle, as well as treating or reducing the severity of a disease or condition in a patient that responds to the inhibition of Janus kinase activity Methods. |
| priorityDate |
2017-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |